Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness

In Italy, a sequential pneumococcal vaccination with conjugate vaccine (PCV) and polysaccharide vaccine (PPSV23) is recommended for individuals aged ≥ 65 years and those at risk for pneumococcal disease (PD) aged ≥ 6 years. The aim of this study was to assess the cost-effectiveness of the new vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Restivo, Vincenzo, Baldo, Vincenzo, Sticchi, Laura, Senese, Francesca, Prandi, Gian Marco, Pronk, Linde, Owusu-Edusei, Kwame, Johnson, Kelly D., Ignacio, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384960/
https://www.ncbi.nlm.nih.gov/pubmed/37515068
http://dx.doi.org/10.3390/vaccines11071253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384960/
https://www.ncbi.nlm.nih.gov/pubmed/37515068
http://dx.doi.org/10.3390/vaccines11071253

Ejemplares similares